Licensed Producers Canada

Welcome. First, a quick age check.

LPC publishes independent cannabis information. Some sections are intended for adults of legal cannabis age in their province or territory.

18+ Alberta 21+ Quebec 19+ elsewhere in Canada

Are you of legal cannabis age where you live?

Anyone can read youth health guidance and confidential support or public cannabis education without confirming their age.

This is a self-declaration, not proof of identity. My LPC membership has a separate, server-checked provincial age requirement. Your public choice stays in this browser.

Skip to content
Today's dateToday
WestVancouver
EastToronto
AtlanticHalifax
Outdoor seasonPost-harvestSeasonResources

LPC News archive · Historical article

Exka Inc. – LP Spotlight

Quebec-based Extraction and Research Lab to Focus on Cannabis Derivatives – LPC

Exka Inc. CEO and Founder, Maxime Paris, on the Mirabel golf course where he built the Exka facility.

Exka Inc. is not the first cannabis extraction specialist in Quebec. But Founder and CEO Maxime Paris said they are the first alternative.

“We are not the only ones in the world, but in Quebec, there is only another one with an extraction licence, Hexo , and another company which is trying to obtain one,” he said. (Please note: all quotes and information are translated from the original French-language Le Journal article. See link to original article below.)

Exka’s 25,000-square-foot, $12-million processing plant was built on an old golf course in Mirabel, a north-west suburb of Montreal. Its focus is on extraction, but the facility also houses a plant tissue culture lab. It plans to create its own products, but also work with licensed producers with their extraction needs. Other related services offered include cloning, micropropogation, and genetic material storage.

The company received its Health Canada Processing and Cultivation licences on February 28, 2020.

Exka to Focus on Derived Cannabis Products – LPC

Initially, Exka will serve the pharmaceutical market. But Paris said he’s open to the recreational market, too.

“We want to supply the pharmaceutical industry – that’s our niche – but the markets will develop towards derived products over the next few years,” he said.

Those derived products include cannabis edibles, topicals, and oils . The article also suggests that Exka would be open to co-creating a cannabis beverage .

Exka expects that demand for extracts will rise by 50% every year. “The advantage of cannabis derivatives is that you can really control what you take.”

According to Le Journal , the cannabis pharmaceutical industry is worth $2 billion, while the recreational industry is $8 billion. About half of the recreational market will be “non-smokable products” including edibles.

Exka is privately owned by “Quebec entrepreneurs” Paris said.

This editorial content from the LPC News Team provides analysis, insight, and perspective on current news articles. To read the source article this commentary is based upon, please click on the link below.

Click here to view full story at www.journaldemontreal.com

External sites may have changed or removed their content since this article was published.

Continue exploring LPC

Read the latest evidence-based reporting or discover curated Health Canada-matched Licensed Producers.